MR contrast developer Epix Medical will be joining the Nasdaq’s Biotechnology Index (NBI).
The listing is effective prior to market opening on Monday, November 24, according to the Cambridge, MA-based vendor.
By AuntMinnie.com staff writersNovember 14, 2003
Related Reading
Epix COO resigns, November 11, 2003
Epix continues to build revenues, trim losses in Q3, October 24, 2003
Epix to present phase III results, September 15, 2003
Epix exercises overallotment option, August 27, 2003
Epix sets share price, August 7, 2003
Copyright © 2003 AuntMinnie.com